Orrick Bolsters Life Sciences Team with Irena Royzman, Formerly at Kramer Levin

Orrick, Herrington & Sutcliffe in New York announced on Monday that Irena Royzman has joined their life sciences team.

Royzman brings a rich palette of experiences to the firm, having engaged in litigation under the Hatch-Waxman Act and Biologics Price Competition and Innovation Act. Her expertise extends to handling cases involving an array of scientific complexities, such as small-molecule drugs, antibodies, other biologics, recombinant DNA technology, gene therapies, and medical devices.

Prior to her move, Royzman held the position of head of the life sciences practice at Kramer Levin. This strategic recruitment reinforces Orrick’s focus on a sector that’s critical for the development and commercialization of medical therapies and technologies.

This update is based on a report originally produced by Bloomberg Law Automation.